Cargando…
Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study
BACKGROUND: To assess the long-term safety and efficacy of monotherapy with a single fresh fecal microbiota transplant (FMT) for recurrent ulcerative colitis (UC). RESULTS: Twenty-six eligible patients were enrolled, and 6 patients were excluded. Ultimately, 20 patients were randomized to the FMT gr...
Autores principales: | Fang, Haiming, Fu, Lian, Li, Xuejun, Lu, Chunxia, Su, Yuan, Xiong, Kangwei, Zhang, Lijiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816432/ https://www.ncbi.nlm.nih.gov/pubmed/33468164 http://dx.doi.org/10.1186/s12934-021-01513-6 |
Ejemplares similares
-
Fecal microbiota transplantation ameliorates active ulcerative colitis
por: Chen, Hui-Ting, et al.
Publicado: (2020) -
Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
por: Sood, Ajit, et al.
Publicado: (2020) -
Optimization of screening strategies for colorectal cancer based on fecal DNA and occult blood testing
por: Yao, Tingting, et al.
Publicado: (2023) -
Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018) -
Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
por: Markandey, Manasvini, et al.
Publicado: (2023)